Close Menu

NEW YORK (360Dx) – GeneNews today said that it has signed a licensing and services deal with Oncore Pharma covering GeneNews' colorectal cancer test outside the US and Canada.

Oncore and its partners will commercialize the ColonSentry test in all countries outside the US and Canada under the five-year exclusive agreement. Initially, the deal will focus on the Netherlands, Belgium, Luxembourg, Germany, France, Switzerland, Austria, Spain, Monaco, Italy, Portugal, the United Kingdom, Ireland, Norway, Sweden, Finland, Denmark, Israel, and the United Arab Emirates.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.